2019
DOI: 10.1016/j.biochi.2018.10.019
|View full text |Cite
|
Sign up to set email alerts
|

Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 57 publications
0
6
0
Order By: Relevance
“…Thus, the identification of the tumor transcriptome and proteome to identify more immunogenic TSAs is helpful. Several highly immunogenic TSAs have already been described [260][261][262][263]. However, modern methods such as high-throughput sequencing technologies and bioinformatics analysis of big data allow the identification of new tumor antigenic determinants, such as neoantigens [264,265].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the identification of the tumor transcriptome and proteome to identify more immunogenic TSAs is helpful. Several highly immunogenic TSAs have already been described [260][261][262][263]. However, modern methods such as high-throughput sequencing technologies and bioinformatics analysis of big data allow the identification of new tumor antigenic determinants, such as neoantigens [264,265].…”
Section: Discussionmentioning
confidence: 99%
“…Glutathione peroxidase assay kit was from Randox (Crumlin, UK). Polyclonal anti-visual arrestin antibodies were previously produced by animal immunization and affinity purification from hyperimmune serum [35]. Mouse monoclonal anti-visual arrestin antibodies were from Santa Cruz Biotechnology (Dallas, TX, USA) (sc-271159).…”
Section: Methodsmentioning
confidence: 99%
“…The content of disulfide dimers of visual arrestin in the retinal extracts was determined by non-reducing Western blotting as described in [20]. The arrestin was visualized using polyclonal (monospecific) antibodies obtained previously (1:10,000 in Tris buffer saline with 0.05% Tween-20 (TBST)) [35]. Alternatively, visual arrestin (C-1) mouse monoclonal IgG1 antibodies were used (1:5000 in TBST).…”
Section: Methodsmentioning
confidence: 99%
“…In-depth research was conducted on SNP and methylation to find new courses for early detection of cancer [203][204][205][206]. The simultaneous detection of SNP and methylation at multiple sites by MNPs is conducive to the early diagnosis and prevention of cancer [207][208][209][210].…”
Section: Discussionmentioning
confidence: 99%